The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms related to this condition, such testosterone therapy cost (click this site) as sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.

Studies have shown that testosterone deficiency is associated with a number of significant health problems like diabetes, obesity, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should get therapy. The truth is, your testosterone levels have probably been slowly declining for some time, a decline that generally begins around age 30.

And many women have a knee jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will probably stay the status quo for some time, given the prohibitive cost of conducting the long term safety studies needed to win more total FDA acceptance.